DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Solér M, Matz J, Townley R. et al.
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
Eur Respir J 2001; 18: 254-261
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.